EXOC2 |
RALA |
||
---|---|---|---|
Gene Name | exocyst complex component 2 | v-ral simian leukemia viral oncogene homolog A (ras related) | |
Image | No pdb structure | ||
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process | |||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 7 interactors: ESX1 EXOC3 EXOC7 EXOC8 RALA SERGEF VPS53 | 32 interactors: ARF1 CALM1 CNKSR2 EXOC1 EXOC2 EXOC3 EXOC4 EXOC5 EXOC6B EXOC7 EXOC8 FLNA HRAS LRPAP1 LSM2 PIH1D2 PLCD1 PLD1 PPP2R1B RAB34 RAB8B RALBP1 RALGPS1 RAP1A RAP2A RAP2B RASSF5 REPS1 RGL2 RGL4 SMAD4 YBX3 | |
Entrez ID | 55770 | 5898 | |
HPRD ID | 11544 | 01549 | |
Ensembl ID | ENSG00000112685 | ENSG00000006451 | |
Uniprot IDs | B2RBE6 Q96KP1 | P11233 | |
PDB IDs | 1UAD 1ZC3 1ZC4 2A78 2A9K 2BOV | ||
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | agouti
albinism
asip
atf1
delta25
dopachrome
edn1
edn3
ednrb
exocyst
kitlg
ludwigshafen
mc1r
microphthalmia
oca2
oculocutaneous
pigmentation
prkacb
prkacg
prkar1a
prkar2a
prkar2b
proopiomelanocortin
slc24a4
slc45a2
tautomerase
tpcn2
tubb3
tyrp1
|
adoptive
antitumor
capability
chimeric
combining
effectors
engineered
fused
genetically
gtp
immunotherapeutic
killer
meaningful
mhc
moieties
ncr1
ncrs
nk
nkp46
partly
proto
ralb
recognition
recognize
regressions
remarkable
retrovirally
termed
|
|
Tagcloud (Difference) ? | agouti
albinism
asip
atf1
delta25
dopachrome
edn1
edn3
ednrb
exocyst
kitlg
ludwigshafen
mc1r
microphthalmia
oca2
oculocutaneous
pigmentation
prkacb
prkacg
prkar1a
prkar2a
prkar2b
proopiomelanocortin
slc24a4
slc45a2
tautomerase
tpcn2
tubb3
tyrp1
|
adoptive
antitumor
capability
chimeric
combining
effectors
engineered
fused
genetically
gtp
immunotherapeutic
killer
meaningful
mhc
moieties
ncr1
ncrs
nk
nkp46
partly
proto
ralb
recognition
recognize
regressions
remarkable
retrovirally
termed
|
|
Tagcloud (Intersection) ? |